astrazeneca - Search News

News

AstraZeneca Books Record Quarterly Revenue

AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth

The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13%.

The Financial Times · 1d

AstraZeneca reports higher sales on record US growth

AstraZeneca has reported a jump in quarterly sales thanks to record growth in its all-important US business, as the UK’s biggest drugmaker prepares to invest billions in the market ahead of potential tariffs.

Free Malaysia Today on MSN · 23h

AstraZeneca’s quarterly net profit jumps on record US growth

The US, a critical market for the pharmaceutical industry, accounted for 44% of AstraZeneca’s total revenue in the second quarter, with US revenue jumping a record 13%. The comp

AstraZeneca, Cancer drug demand

Reuters on MSN · 20h

AstraZeneca tops expectations on robust drug sales, US demand

AstraZeneca on Tuesday beat second-quarter revenue and profit expectations on robust sales of newer cancer, heart and kidney disease medicines and strong demand in the U.S., where it has invested $50 billion to expand amid tariff threats from Washington.

Bloomberg on MSN · 18h

AstraZeneca Weighs Direct-to-Patient Drug Sales in US

AstraZeneca Plc may sell some of its medicines directly to patients in the US, joining several other drugmakers that have plans to bypass middlemen or are considering them.

PA Media on MSN · 20h

Cancer drug demand drives higher sales for AstraZeneca

AstraZeneca has announced a jump in sales in recent months after a surge in demand for cancer drugs, as the pharmaceutical giant prepares to plug 50 billion dollars (£37 billion) into its US expansion.

16hon MSN

AstraZeneca seeks US drug price cuts amid expansion plans, strong demand

AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 ...

11hon MSN

Why AstraZeneca Stock Was Topping the Market on Tuesday

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

BioSpace15h

AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D

Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...

AstraZeneca Profit, Revenue Lifted by Cancer Drugs

AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer ...

AstraZeneca share price forecast after earnings

AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.

InsideNoVa on MSN7d

AstraZeneca to build its largest-ever manufacturing facility in Virginia, creating hundreds of jobs

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...

7don MSN

AstraZeneca investing $50B in US, Trump calls it an ‘honor’

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump ...

8don MSN

AstraZeneca to invest $50B in US economy by 2030

British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...

18hon MSN

AstraZeneca Stock Rises as US, Cancer Drugs Growth Lifts Q2 Results

AstraZeneca shares are rising in premarket trading Tuesday after the pharma giant beat second-quarter estimates on strong U.S ...

Fierce Biotech23h

AstraZeneca drops lead T-cell receptor therapy from $200M Neogene buy

AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results